Summary Marine carotenoids have been reported to prevent and alleviate lifestylerelated diseases including diabetes and obesity. We previously reported that siphonaxanthin, a green algal carotenoid, effectively suppresses adipogenesis in 3T3-L1 cells and prevents lipid accumulation in mesenteric adipose tissue of KK-Ay mice. Thus, we expect that dietary siphonaxanthin-rich marine green algae may effectively prevent obesity. Here, we assessed the effect of dietary siphonaxanthin-rich green algae (Codium cylindricum) on the development of diet-induced obesity in C57BL/6J mice. The mice were fed a low-fat diet (LF; 7% fat, w/w), a high-fat diet (HF; 35% fat, w/w), or a high-fat diet supplemented with 1% or 5% green algal powder (1GA or 5GA) for 78 d. Our results showed that weights of body and perirenal white adipose tissue (WAT) in the 5GA group were significantly lower than that in the HF group. The mesenteric and total WAT, as well as plasma and hepatic cholesterol concentrations tended to be lower in both the 1GA and 5GA groups compared to the HF group. Dietary green algal powder reduced the expression of lipogenesis-related genes and enhanced the expression of energy expenditure-related genes in the mesenteric WAT. Siphonaxanthin accumulated in the mesenteric WAT may contribute to the prevention of adiposity in mesenteric WAT. Furthermore, the reduction in the weight of WAT was attributed to the inhibitory effect on fat absorption of dietary fiber contained in the green algae. Overall, these results indicated that siphonaxanthin-rich green algae may be beneficial for the prevention of obesity and regulation of lipid metabolism.
Obesity has reached pandemic proportions in recent years, which has resulted in an increasing health care burden and decreasing life expectancies. In particular, abdominal obesity is emerging as a prevalent cause of metabolic syndrome and related cardiometabolic risk (1) . The majority of patients with obesity have dysfunctional adipose tissue, which is characterized by an impairment of insulin sensitivity, an alteration of fatty acid metabolism and a disruption of adipokine secretion, which have inflammatory, atherogenic and diabetogenic properties (2, 3) . Anti-obesity drugs, such as orlistat and sibutramine, are believed to achieve very modest weight loss and are approved for long-term clinical use; however, side-effects are inevitable (4) . Therefore, natural products possessing anti-obesity potential are being explored, which may lead to a promising strategy for prevention and treatment of obesity.
A wide variety of extracts and compounds from terrestrial plants, including their seed, leaf, and root, have been reported to possess potential anti-obesity effects via distinct mechanisms (5) . On the other hand, marine plants, such as algae, have generally been used in many coastal regions as a source of food, industrial applications, or fertilizer. In recent years, marine algae, which serve as an excellent source of functional and bioactive compounds, have received greater attention. Dietary supplementation with edible brown algae, such as tororokombu and Sargassum polycystum, has been reported to inhibit the development of obesity (6, 7) . The brown algal carotenoid, fucoxanthin, which has been revealed to have a remarkable anti-obesity property in mice, rats and human subjects (8, 9) , is a major contributor to these inhibitory effects (8, 9) . Both fucoxanthin-rich seaweed extract and purified fucoxanthin are equally effective in reducing adipose tissue weight and regulating lipid metabolism (10, 11) .
Edible green algae, such as Codium fragile, Caulerpa lentillifera, Umbraulva japonica, and Codium cylindricum, have been used as foodstuffs in many coastal countries, including Japan. However, the functional effects of dietary green algae are still poorly understood. The above-mentioned edible green algae contain a special keto-carotenoid, siphonaxanthin, which is structurally different from fucoxanthin. We previously reported that siphonaxanthin inhibited a viability of human leukemia HL-60 cells via induction of apoptosis more potently than fucoxanthin (12) . Siphonaxanthin exhibits anti-angiogenic activity evaluated by assays using human umbilical vein endothelial cells and the rat aortic ring more effectively than fucoxanthin (13, 14) . Notably, we recently found that siphonaxanthin inhibits adipogenesis in 3T3-L1 preadipocytes, and lipid accumulation in white adipose tissue (WAT) of KK-Ay mice (15) . Our preliminary data shows that the content of siphonaxanthin in these green algae harvested in different seasons is approximately 20-230 mg/g. The purification of siphonaxanthin from algae for nutraceutical utilization is technically difficult. Thus, direct application of siphonaxanthin-rich green algae as a foodstuff might be a promising strategy. However, the benefits of dietary green algae in obesity remain poorly understood.
In this study, we used the siphonaxanthin-rich green alga C. cylindricum to evaluate its anti-obesity effect. The content of siphonaxanthin in C. cylindricum is relatively higher than in other species of edible green algae. We investigated the effect of dietary C. cylindricum powder on high-fat diet-induced obesity in C57BL/6J mice. We further elucidated the underlying molecular 1 Low-fat diet: AIN-93G diet. LF, low fat diet group; HF, high-fat diet group; 1GA, 1% green algae powder-supplemented group with a high fat diet; 5GA, 5% green algae powder-supplemented group with a high fat diet. 
MATERIALS AND METHODS
Preparation of green algal powder. Edible green algae (C. cylindricum) used in this study was kindly donated by the Mie Prefecture Fisheries Research Institute, Japan. After thoroughly washing with water to remove debris, epiphytes and salt, the algae were freeze-dried and pulverized into a fine powder using a grinder. The sample was stored at 220˚C until use. The nutrient composition of algal powder was analyzed (Table 1) .
Animals and diets. All experimental animal protocols were approved by the Animal Experimentation Committee of Kyoto University for the care and use of experimental animals (Approval No. . Male C57BL/6J mice (4 wk of age) were purchased from Charles River Laboratories, Japan, Inc. (Tokyo, Japan). All mice were housed individually in plastic cages and maintained on an alternating 12-h light/dark cycle at a temperature of 2361˚C. After an acclimatization period of 1 wk, the mice were randomly divided into 4 experimental groups (n56 per group). The low-fat fed-group (LF) was fed with a purified diet (AIN-93G diet) containing 7% by wt. fat (16) . The high-fat fed-group (HF) was fed a modified AIN-93G diet containing 35% by wt. fat (Table 2) , and the other two groups were fed an HF diet supplemented with 1 or 5% by wt. frozen-dried green algae powder (1GA or 5GA). The body weights and food consumption of mice were recorded every day throughout the study. After 78 d of dietary treatments, mice were feed-deprived for 16 h and euthanized under isoflurane anesthesia. Blood was collected, and organs including white and brown adipose tissues, liver, and muscle were rapidly removed, weighed, and stored in RNA later TM solution (Ambion, Austin, TX).
Measurement of plasma biochemical parameters. Plasma was prepared by centrifugation at 400 3g for 15 min at 4˚C, and stored at 280˚C until analysis. Plasma levels of triacylglycerol (TG), free cholesterol, total cholesterol (TC), HDL-cholesterol (HDL-C), nonesterified fatty acid (NEFA), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and glucose were determined using commercially available kits (TG E, F-Cho E, T-Cho E, HDL-C E, NEFA C, GOT·GPT C II, Glu C II; Wako Pure Chemical Industries, Ltd., Osaka, Japan).
Measurement of TG and TC levels in the liver and feces. Aliquoted liver samples from each group were homogenized in a 9-fold volume of 0.9% NaCl saline with a Teflon-glass homogenizer. Hepatic lipids were extracted from each homogenate with chloroform/methanol (2 : 1, v/v). Feces were collected on a per-cage basis for 24 h after 35 d of feeding. Feces were ground under liquid nitrogen with a porcelain mortar and pestle until a fine powder was obtained. Fecal total lipids were then extracted with H 2O/chloroform/methanol (0.9 : 2 : 1, v/v/v). The lipid samples were dissolved in methanol containing 50% Triton X-100 and then assayed for TG, TC and NEFA levels using commercial enzymatic kits as mentioned above, respectively.
RNA extraction and quantitative real-time RT-PCR. Total RNA was extracted from the frozen tissues using Sepasol ® -RNA I Super G (Nacalai Tesque, Inc., Kyoto, Japan), as described in the manufacturer's instructions, and was treated with DNase (Wako). Then, 2 mg of total RNA from each sample was reverse-transcribed . Statistical significance as revealed by a repeated-measures two-way ANOVA (time3treatment), followed by Tukey's test. Within each graph, labeled means without a common letter are significantly different among groups at p,0.05. LF, low fat diet group; HF, high fat diet group; 1GA, 1% green algae powder-supplemented group with a high fat diet; 5GA, 5% green algae powder-supplemented group with a high fat diet.
to cDNA using a SuperScript RNase II reverse transcriptase kit (Invitrogen, Carlsbad, CA) with random hexamers. For RT-PCR, cDNA was diluted and mixed with iQ SYBR green supermix (Bio-Rad Laboratories) containing 1 mmol/L PCR primer. Primers used for the quantification of each gene are listed in Table 3 . Quantitative real-time PCR was performed using a DNA Engine Option system (Bio-Rad Laboratories). The PCR protocol included the following thermal cycling conditions: one cycle at 95˚C for 15 min, followed by 43 cycles at 95˚C for 15 s and 60˚C for 30 s. The mRNA expression level of each gene was normalized to Gapdh expression. Measurement of siphonaxanthin content in dried green algal powder and biological samples. Carotenoids were extracted from algal powder, feces, WATs, and liver tissue. Briefly, tissue sample aliquots (0.2 g) were homogenized in a 9-fold volume of 0.9% NaCl saline with a homogenizer dispenser (T10 basic Ultra-Turrax, IKA, Germany). To extract carotenoids, the resultant tissue homogenates (0.9 mL) were mixed with 3 mL of dichloromethane/methanol (2 : 1, v/v). Freeze-dried algal powder (0.03 g) and mouse fecal powder (0.1 g) as described above were mixed with 3.9 mL of water/ dichloromethane/methanol (0.9 : 2 : 1, v/v/v), respectively. The samples were extracted three times, and the dichloromethane layer was collected after centrifugation at 1,690 3g at 4˚C for 15 min. After evaporation under nitrogen, the residue was resuspended in 100 mL of dichloromethane/methanol (1 : 1, v/v) for HPLC analysis.
HPLC analysis. HPLC analysis was performed with a Prominence LC system (Shimadzu, Kyoto, Japan) connected to a photodiode array detector (SPD-M20A, Shimadzu) followed by an ion trap-time of flight mass spectrometer (LCMS-IT-TOF, Shimadzu) equipped with an atmospheric pressure chemical ionization (APCI) source. Carotenoids were separated on a TSK gel ODS80Ts QA column (2.03250 mm, 5 mm, Tosoh, Tokyo, Japan). The mobile phase was methanol/water (83 : 17, v/v) containing 0.1% ammonium acetate at a flow rate of 0.2 mL/min. The peak identities for carotenoids were confirmed from their characteristic recorded UV-VIS spectra and recorded positive ions. Siphonaxanthin was quantified from its peak area by use of a standard curve using purified siphonaxanthin.
Statistical analysis. Data analyses were performed using the statistical program SPSS 16.0 for Windows. Comparisons were made among groups of normally distributed data using one-way ANOVA followed by Tukey's multiple comparison test. Data with unequal variances were transformed to logarithms. The changes in weight gain, food intake, and energy intake were analyzed by using a repeated-measures two-way ANOVA (time3treatment), and then followed up by Tukey's test to examine the differences in the different experimental groups at each time point. Data are represented as means6SE. Statistical significance was defined as p,0.05.
RESULTS

Effect of dietary green algae on body weight and adiposity
Body weight gain of the four groups of mice was compared after 78 d of feeding (Fig. 1A) . The HF diet resulted in a significant increase in body weight gain of mice compared with the LF diet. The body weight gain of mice fed an HF diet containing 1 or 5% algal powder increased less than that of mice fed the HF diet. The difference became significant from 10 wk after the dietary treatment in the 5GA group. During the experimental period, the food intake was significantly higher in mice fed an LF diet than in mice fed an HF diet, but was not significantly different between the HF and 1GA or 5GA groups (Fig. 1B) . The food intake per day per mouse was weighed in all groups for calculation of energy intake. There were no significant differences in the average energy intake of mice fed each diet (Fig. 1C) . The weights of the mesenteric, perirenal, epididymal and total WAT were significantly increased by the HF diet compared to the LF diet (Fig. 2) . Compared to the HF group, the weight of the epididymal WAT was unchanged in the WAT, white adipose tissue; BAT, brown adipose tissue. LF, low fat diet group; HF, high fat diet group; 1GA, 1% green algae powdersupplemented group with a high fat diet; 5GA, 5% green algae powder-supplemented group with a high fat diet.
algal powder-supplemented mice; however, the weight of the perirenal WAT in both the 1GA and 5GA groups was significantly decreased, and the weights of mesenteric (p50.06) and total WAT (p50.09) tended to be lower in the 5GA group (Fig. 2) . On the other hand, the weights of liver and interscapular brown adipose tissue (BAT) did not change among the groups (Fig. 2) . Table 4 shows the major biochemical parameters in plasma, liver, and feces. The plasma TG, NEFA, and glucose concentrations were not significantly different between the groups. The plasma TC concentrations tended to be lower in the two algal powder-supplemented groups than in the HF group (p50.08 and p50.10, respectively). The plasma HDL-C concentration was not significantly changed by algal powder supplementation. The HF diet significantly increased plasma aspartate transaminase (AST) and alanine transaminase (ALT) activities as compared to the LF diet; in contrast, the 5GA group showed significantly decreased enzyme activities as compared to the HF group.
Effects of dietary green alga on parameters in plasma, liver, and feces
Hepatic TG concentration was significantly increased in the HF group compared to the LF group. Hepatic TC concentration was not significantly different between the LF and HF groups; however, its concentration tended to be lower in the 1GA (p50.10) and 5GA (p50.07) groups compared with the HF group. Moreover, the weight of feces collected for 24 h was significantly higher in the 5GA group than in the HF group, and the fecal TG and NEFA concentrations in the 5GA group were significantly elevated compared to the HF group. The fecal TC concentration was not significantly different between the HF group and the algal powder-supplemented groups. . Labeled means without a common letter are significantly different among groups at p,0.05, as determined by Tukey's test. LF, low fat diet group; HF, high fat diet group; 1GA, 1% green algae powder-supplemented group with a high fat diet; 5GA, 5% green algae powder-supplemented group with a high fat diet. 
Effects of dietary green algae on mRNA expression of genes related to lipid metabolism in the liver
The mRNA levels of the lipid metabolism-related genes in the liver were analyzed by real-time RT-PCR (Fig. 3) . The mRNA levels of the transcription factor sterol regulatory element binding protein 1c (Sr) and its target gene, fatty acid synthase (Fasn), which regulates lipid synthesis in the liver, were not significantly different among the groups. The mRNA level of stearoyl CoA desaturase 1 (Scd1), one of the target genes of Srebf1, tended to be lower in the 1GA group compared with the HF group (p50.06). Furthermore, the mRNA levels of b-oxidation-related genes were also analyzed. The differences in the mRNA expression of peroxisome proliferator-activated receptor alpha (Ppara) were not significant among these experimental groups. However, the mRNA levels of carnitine palmitoyltransferase 1 alpha (Cpt1a) and acyl-CoA oxidase 1 (Acox1) were significantly reduced in the 5GA group compared with the HF group.
Effects of dietary green algae on mRNA expression of genes related to lipid metabolism in adipose tissue
The effects of dietary green algae on the expression of adipogenic factors and lipid-regulating enzymes in WATs were investigated using real time RT-PCR. In the mesenteric WAT, the mRNA levels of fatty acid synthesisrelated genes, including Srebf1, Fasn, Scd1 and glucose-6-phosphate dehydrogenase (G6pdx) were measured. The mRNA expression of Srebf1, Fasn, Scd1, and G6pdx was significantly reduced in the 5GA group compared with the HF group (Fig. 4A) . The 5% algal powder-supplemented diet significantly down-regulated the mRNA expression of peroxisome proliferator-activated receptor gamma (Pparg), which is a crucial transcription factor in adipogenesis, compared with the HF diet (Fig. 4A) . Regarding the expression of fatty acid oxidation-related genes, the Cpt1a mRNA expression was not significantly different between the experimental groups, while Acox1 mRNA expression was significantly reduced in both algal powder supplemented-groups compared with the HF group. In contrast to the lipogenic genes analyzed, the mRNA expression of the energy expenditure-related gene PPAR gamma coactivator 1 alpha (Ppargc1a) was significantly up-regulated in the 5GA group, while the mRNA expression of PPAR gamma coactivator 1 beta (Ppargc1b) was not significantly different between the HF group and the 5GA group.
In the perirenal WAT, the mRNA expression levels of lipogenic genes involving Srebf1, Fasn, Scd1 and G6pdx did not significantly differ between the GA and HF groups. Unlike in mesenteric WAT, in the perirenal WAT, Pparg expression was significantly enhanced in the 5GA group compared to the HF group (Fig. 4B ). In the perirenal WAT, Cpt1a expression was significantly increased, and Acox1 expression tended to be higher (p50.06) in the 5GA group compared with the HF group; the expression of Ppargc1a and Ppargc1b was not significantly altered in the 5GA group compared with the HF diet (Fig.  4B ). In the epididymal WAT, mRNA expression levels of the above-mentioned genes evaluated in WATs were not significantly altered by algal powder supplementation compared with the HF diet (Fig. 4C ). Moreover, the mRNA level of adiponectin (Adipoq), the expression of which is decreased under conditions of obesity (17), was not significantly changed in any WATs in the GA groups compared with the HF group. The mRNA expression of uncoupling protein 1 (Ucp1) in perirenal WAT was not changed between the GA groups and the HF group (data not shown). The mRNA expression of Ucp1 could not be detected in the mesenteric or epididymal WAT by realtime PCR.
Accumulation of siphonaxanthin in the mesenteric WAT of mice fed green algal powder
The content of siphonaxanthin in C. cylindricum used in this study was 230 mg/g; neoxanthin, violaxanthin, lutein, siphonein and a-carotene were also detected (Fig.  5B) . To evaluate the utilization efficiency of siphonaxanthin from dietary algal powder, siphonaxanthin accumulation was investigated in adipose tissues and the liver. Siphonaxanthin was found to accumulate in the mesenteric WAT following green algal powder supplementation (1.4860.20 ng/g and 5.5761.80 ng/g tissue in the 1GA and 5GA groups, respectively), although siphonaxanthin was not detected in the liver, perirenal WAT or epididymal WAT. Further, to understand the absorption efficiency of siphonaxanthin from dietary algal powder in mice, fecal excretion of siphonaxanthin was determined. The excretion of siphonaxanthin was calculated from the ratio of fecal siphonaxanthin content to siphonaxanthin intake for 24 h. The cumulative excretions of siphonaxanthin were 37.261.3% and 57.661.2% in the 1GA and 5GA groups, respectively.
DISCUSSION
In this study, the effects of dietary supplementation of the green algae C. cylindricum on the development of diet-induced obesity in C57BL/6J mice were evaluated. It was observed that dietary green algae significantly reduced high-fat diet-induced body weight gain and perirenal fat accumulation, and showed a tendency to reduce mesenteric and total WATs, and plasma cholesterol concentration. Dietary supplementation of dietary green algae led to the restoration of both plasma AST and ALT to normal levels. Our results showed that dietary green algae would be effective in improving dietinduced damage of the liver.
The anti-obesity potential of edible algae has also been reported in several studies. For instance, Miyata et al. reported that dietary supplementation of tororokombu, an edible kelp product, inhibited fat absorption, lowered body weight, and reduced parauterine adipose tissue in obese mice induced by a 63-d high-fat dietary course (6) . It was reported that dietary supplementation of the brown algae Sargassum polycystum inhibited weight gain and ameliorated elevated plasma lipids and glucose levels in rats fed a high-fat diet (7) . The positive effect of these algae has been accounted for by the presence of a high amount of dietary fiber and anti-obesity active compounds, including carotenoids. However, the molecular mechanism underlying the inhibitory effect of these algae was uncertain.
The expression of the adipogenic transcription factor (Pparg) and lipogenic transcription factor (Srebf1), and their target genes (Fasn and Scd1) was reported to be elevated in the adipose tissues of high-fat diet-induced mice, and several natural products possessing anti-obesity properties attenuate their expression (18) (19) (20) (21) . Likewise, dietary supplementation with C. cylindricum also significantly reduced high-fat diet-induced expression of lipogenic genes in the mesenteric WAT; however, the same effects were not observed in the perirenal or epididymal WAT. On the other hand, the enhancement of b-oxidation has been recognized as one possible mechanism for prevention against obesity (5) . Cpt1a and Acox1 are rate-limiting enzymes which regulate fatty acid oxidation in mitochondria (22, 23) . High expression levels of Cpt1a and Acox1 are consistent with increased triacylglycerol catabolism in the liver and adipose tis- sue (24, 25) . In this study, dietary green algae did not enhance the expression of b-oxidation genes in the mesenteric WAT, but instead prevented the increase of those by a high-fat diet, while in the perirenal WAT, the 5% algal powder-supplemented diet significantly increased expression levels of Cpt1a and Acox1. Pparg is known as the most important pleiotropic transcription factor in adipocyte differentiation, and its up-regulation is considered beneficial for the normalization of the functionality of endocrine adipose tissues to produce adipokines, including adiponectin (26) . In this study, the 5% algal powder-supplemented diet significantly increased the expression of Pparg in the perirenal WAT, while significantly decreasing the expression of Pparg in the mesenteric WAT. The non-uniform effects of dietary green algae on lipid synthetic and oxidative pathways in WATs might be due to different anti-obesity mechanisms. This study also aimed to evaluate whether the bioactive carotenoid siphonaxanthin contributes to the prevention of obesity in mice orally supplemented with powdered green algae. In our previous study, we found that the weight of visceral fat, especially the mesenteric WAT, was significantly reduced after oral administration with 1.3 mg siphonaxanthin for 6 wk in diabetic KK-Ay mice (15) . To understand the contribution of siphonaxanthin to the anti-obesity effect, the accumulation of siphonaxanthin in WATs of mice following supplementation of green algal powder was further determined. The accumulation of siphonaxanthin was confirmed in the mesenteric WAT only, and was not in perirenal or epididymal WATs. Correspondingly, these findings indicated that the down-regulation of lipogenesis-related gene expression in mesenteric WAT by the supplementation of green algal powder would be mainly caused by preferential accumulation of siphonaxanthin. In fact, it was shown that siphonaxanthin administration to KK-Ay mice prevented the adiposity in the mesenteric WAT via the down-regulation of lipogenesis (15) . The calculated average daily intake of siphonaxanthin in this study (31.1 mg/d/mouse in the 5GA group) is far lower compared with the dosage of the previous study using siphonaxanthin concentrate (1.3 mg/d/mouse) (15) . In the present result, therefore, the weight of mesenteric WAT tended to be lower, though lipogenic genes were down-regulated. In addition, absorption of siphonaxanthin from dietary algae was not efficient, because the excretion of siphonaxanthin in 24 h was greater than approximately 40%. It has been speculated that the high dietary fiber content of the algae (70.7% in dried powder) could decrease the absorption of carotenoids (27, 28) . Thus, enhancement of siphonaxanthin bioavailability might be an effective strategy for exerting its full potential.
It is generally known that marine algae contain many kinds of dietary fiber, the levels of which are typically higher compared with terrestrial foodstuffs (29, 30) . The main components of algal dietary fibers are alginates, carrageenans, and agar, among other components, depending on the type of algae (29) . Epidemiologic evidence suggests that dietary fiber intake aids in weight management via many mechanisms, including promoting satiety, decreasing absorption of fat, and altering secretion of gut hormones (31, 32) . Some fibers found in algae have been reported to be associated with weight loss. For instance, sodium alginate from brown algae is used worldwide as a weight-loss supplement (33, 34) ; fucoidan extracted from brown algae has been shown to have inhibitory effects on adipocyte differentiation (35, 36) ; and porphyran from red algae has been shown to improve glucose metabolism and up-regulate plasma adiponectin concentrations (37) . However, to date, there has been no information regarding the potential anti-obesity effect of green algal polysaccharides. We determined that the green alga C. cylindricum used in this study contained 70.7% dietary fiber as dried powder ( Table 2 ). The effect of dietary green algae on body weight loss might partly result from its high soluble fiber content, which helps to slow digestion and fat absorption. Dietary fiber has been reported to promote satiety by delaying gastric emptying and absorption of nutrients into the small intestine, and thus decrease food intake (31) . However, algal powder supplementation did not affect food intake compared with the control HF diet group. Instead, the enhancement of fecal weight, and increased fecal TG and NEFA concentrations in the high dosage GA group was observed. The increase in fecal TG and TC, which correlates with a decreased intestinal absorption of lipids, can lead to a reduction of plasma and hepatic TG and TC concentrations. Similarly, Miyata et al. reported that dietary consumption of the brown alga tororokombu resulted in increased fecal TG and TC levels (6) . The results may be explained by the presence of dietary fiber, which is known to facilitate formation of large and soft stools, and to slow absorption of dietary fat (38, 39) . The suppressive effect of dietary green algae on lipid absorption might contribute to the weight loss of WATs, especially perirenal WAT, in which the expressions of lipogenesis-related genes were not significantly altered.
Our results suggest that the green algae can improve lipid metabolism and protect against obesity. In the study, 1% or 5% supplement of green algae powder is equivalent to a daily dosage of 1.3 g/kg or 6.5 g/kg (body weight) based on the calculation using mice average food intake (2.6 g) and mouse standard weight (20 g ). By using the body surface area normalization method (40), a person weighing 60 kg would gain a similar beneficial effect by consuming 6.4 g (corresponding to 1%) or 31.6 g (corresponding to 5%) of green algae powder daily.
In conclusion, our study indicated that supplementation with siphonaxanthin-rich green algae exerted antiobesity effects. Dietary green algae reduced WAT weight and ameliorated elevated plasma and hepatic lipid profiles via the regulation of lipid metabolism in adipose tissue, and the inhibition of lipid absorption. These results revealed that siphonaxanthin-rich green algae might be used as an effective foodstuff to help prevent and control obesity.
